Axonics Inc (AXNX) Stock News

USA - NASDAQ:AXNX - US05465P1012 - Common Stock

70.98 USD

+0.53 (+0.75%)

Last: 11/14/2024, 8:04:51 PM

70.98 USD

0 (0%)

After Hours: 11/14/2024, 8:04:51 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AXNX Latest News, Press Relases and Analysis

All

Press Releases

3 months ago - By: RxSight, Inc. - Mentions: RXST KMTS NSPR

RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors

a year ago - By: Boston Scientific Corporation - Mentions: BSX

Boston Scientific Closes Acquisition of Axonics, Inc.

a year ago - By: Axonics, Inc.

Axonics Reports Third Quarter 2024 Financial Results

a year ago - By: Axonics, Inc.

Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia

2 years ago - By: BusinessInsider

News Image

AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024

a year ago - By: Axonics, Inc.

Axonics Prevails in Patent Infringement Lawsuit with Medtronic

a year ago - By: Axonics, Inc.

Axonics Reports Second Quarter 2024 Financial Results

a year ago - By: InvestorPlace - Mentions: PATH IRTC ISRG TER ...

7 Robotics Stocks That Could Grow Your Wealth

1 years ago - By: Axonics, Inc.

Axonics Receives Regulatory Approval for Recharge-Free SNM System in Australia

2 years ago - By: Benzinga

Beyond The Numbers: 7 Analysts Discuss Axonics Stock

2 years ago - By: Benzinga

Analyst Scoreboard: 5 Ratings For Axonics

2 years ago - By: The Motley Fool - Mentions: BSX

Why Axonics Stock Soared Today

2 years ago - By: InvestorPlace

AXNX Stock Earnings: Axonics Misses EPS, Beats Revenue for Q1 2024

2 years ago - By: Axonics, Inc.

Axonics Reports First Quarter 2024 Financial Results

2 years ago - By: Boston Scientific Corporation - Mentions: BSX

Boston Scientific Announces Results for First Quarter 2024

2 years ago - By: Axonics, Inc.

Axonics Stockholders Approve Merger Agreement with Boston Scientific

2 years ago - By: Axonics, Inc.

Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System

2 years ago - By: Bloomberg - Mentions: BSX

Boston Scientific Likely Faces FTC Scrutiny on $3.7 Billion Axonics Deal

2 years ago - By: Seeking Alpha - Mentions: MDT

Medtronic accuses Axonics of patent infringement, files ITC complaint (NASDAQ:AXNX)

2 years ago - By: Axonics, Inc.

Axonics Responds to ITC Action by Medtronic

2 years ago - By: Axonics, Inc.

Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results

2 years ago - By: Kahn Swick & Foti, LLC

AXONICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Axonics, Inc. - AXNX

2 years ago - By: Boston Scientific Corporation - Mentions: BSX

Boston Scientific Announces Results for Fourth Quarter and Full Year 2023

2 years ago - By: Brodsky & Smith LLC - Mentions: AMAM JNJ GRCL AZN ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)

2 years ago - By: Investor's Business Daily - Mentions: NVDA TSLA JPM UNH ...

Stock Market Rally Rebounds; Nvidia, Tesla, JPMorgan, Bitcoin ETFs In Focus: Weekly Review

2 years ago - By: InvestorPlace - Mentions: TSLA AMZN BSX CTRA ...

10 Top Stocks With a Strong Buy Rating Right Now

2 years ago - By: Brodsky & Smith LLC - Mentions: AMAM JNJ GRCL AZN ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Ambrx Biopharma, Inc. (Nasdaq – AMAM), Gracell Biotechnologies Inc. (Nasdaq – GRCL), Axonics, Inc. (Nasdaq - AXNX), Harpoon Therapeutics, Inc. (Nasdaq - HARP)